Low muscle oxidative capacity contributes to exercise intolerance in chronic obstructive pulmonary 31 disease (COPD). Near-infrared spectroscopy (NIRS) allows non-invasive determination of the 32 muscle oxygen consumption ( O2) recovery rate constant (k), which is proportional to oxidative 33 capacity assuming two conditions are met: 1) exercise intensity is sufficient to fully-activate 34 mitochondrial oxidative enzymes; 2) sufficient O2 availability. We aimed to determine 35 reproducibility (coefficient of variation, CV; intraclass correlation coefficient, ICC) of NIRS k 36 assessment in the gastrocnemius of 64 participants with (FEV1 64±23%predicted) or without COPD 37 (FEV1 98±14%predicted). 10-15s dynamic contractions preceded 6min of intermittent arterial 38 occlusions (5-10s each, ~250mmHg) 
INTRODUCTION 51
Chronic obstructive pulmonary disease (COPD) is characterized by dyspnea on exertion, with 52 subsequent reduced exercise tolerance and quality of life. Skeletal muscle dysfunction is a systemic 53 consequence of COPD that also contributes to increased morbidity and mortality in this population 54 (Agustí et 1998). Amelioration of these muscular alterations contributes to the substantial benefits of 61 pulmonary rehabilitation in COPD patients (Maltais et al., 2014) . 62
63
The prevalence and progression of the loss of muscle oxidative phenotype in relation to disease 64 NCT00608764), for which a complete list of inclusion and exclusion criteria is given in Regan et al. 115 (2010) . Participants were informed about the procedures and risks associated with the study, and 116 gave written informed consent. oxy-hemoglobin and oxy-myoglobin (HbO2) in the tissues ~1.5 cm beneath the probe (interoptode 128 distance was 3 cm). From these measurements relative changes in total hemoglobin and myoglobin 129 (THb = HHb+HbO2) and the Hb difference (Hbdiff = HbO2-HHb) were calculated. In addition, the 130 tissue saturation index (TSI, %) was measured using the SRS approach (using interoptode distances 131 of 2-3 cm) (Ferrari et al., 2004) . gastrocnemius, and secured with an elastic bandage. A 13 x 85 cm rapid-inflation pressure-cuff 136 (SC12D, Hokanson, USA) was placed on the proximal thigh of the same leg and attached to an 137 electronically-controlled rapid cuff-inflator (E20, Hokanson, USA). A pad was placed under the ankle 138 such that the lower leg and NIRS probe was suspended above the bed. During the ~30 min 139 assessment, the participant was asked to relax and refrain from moving the leg except when 140 instructed. 141 142 Initially, the participant was familiarized with the execution of cyclical plantar-flexion/relaxation 143 exercise at ~1Hz, to activate the medial gastrocnemius against a manually applied resistance, and 144 with the rapid-cuff inflation procedures. Repeated cuff inflations from low (~50 mmHg) to high 145 (~250 mmHg) pressures were performed during this familiarization phase. Arterial occlusion wasdetermined from a tolerated cuff-pressure within the range of 230-300 mmHg (236±17 mmHg) that 147 resulted in HHb rise, HbO2 fall and approximately constant THb over ~15-20 s. 148
149
The measurement protocol began after 2-3 min of rest, where baseline TSI and SpO2 at a fingertip 150 (Rad-5 Pulse Oximeter MasimoSET®, Masimo Co., Irvine, CA) were measured over 2 min. 151
Subsequently, after having removed the pulse oximeter, the participant was instructed to execute 152 10-12 cycles of plantar-flexion exercise, followed immediately by arterial occlusion until a steady-153 state in TSI was reached (mean duration ~90 s; Figure 1 (Figure 2A,C) . Note that during occlusion the rate of deoxygenation (the negative slope of TSI) 180 is inversely proportional to O2, and is therefore reported below as a positive value (%.s -1 ). The 181 O2 exponential recovery rate constant (k, min -1 ) was estimated using non-linear least-squares 182 regression ( Figure 2B,D) performed for the study. On average, there was no difference between repeated k measurements 232 within COPD or CON participants ( Table 2) (the primary outcome). In all participants, Bland-Altman limit of agreement analysis revealed low 236 mean bias (-0.03min -1 ), and 95% confidence intervals of -0.58, 0.64 min -1 ( Figure 4 ). We could 237 detect no order effect between repeats of k measurement (P = 0.24; 1-tailed t-test). On average, 238
O2 k was ~25% lower in COPD than CON (Table 2) and was diminished at all GOLD stages: CON, 239
1.74 ± 0.71 min -1 (n=28); GOLD 1, 1.45 ± 0.36 min -1 (n=7); GOLD 2, 1.48 ± 0.37 min -1 (n=13); GOLD 3, 240
1.22 ± 0.32 min -1 (n=5); and GOLD 4, 1.54 ± 0.41 min -1 (n=3).
242

NIRS test quality control. During the oxidative capacity test, the lowest TSI (TSILOW) in both 243
repeats was typically achieved within the first or second AO (e.g., see Figure 1 ). In both COPD and 244 CON, TSILOW averaged ~47% absolute (Table 3) , equivalent to ~32% and ~29% of the PN range 245 respectively. On average, the TSI deflection point occurred at 46 ± 9 % in COPD and 46 ± 11 % in 246 CON. This meant that, typically (66% of tests), TSILOW was greater than TSI deflection point. In 38 247 tests (27%) TSILOW was below TSI deflection point. 248
249
In COPD, the peak O2 during the oxidative capacity test was 1.38±0.59 %.s -1 and 1.51±0.88 %. variability threshold. These unreliable tests were characterized by a low O2 (TSI = 1.15 ± 268 0.44 %.s -1 ) and poor exercise deoxygenation (e.g. a high TSILOW value of 53.5 ± 5.8 %). Six of these 269 participants had large adipose layer (ATT = 8.3 ± 3.0 mm) and six had high skin melanin, each likely 270 limiting the volume of the muscle interrogated by the NIRS probe. In all these 13 participants, the 271 lowest TSI during the test (TSILOW) was below the TSI deflection point, suggesting that low O2 272 availability was not associated with muscle oxidative capacity assessment reliability. Excluding tests 273 on the basis of k > 0.3 min -1 improved k measurement reliability (CV = 7.0±4.3%, ICC = 0.98, n = 274 43). 275 276
DISCUSSION 277
This is the first study to measure locomotor muscle oxidative capacity (from O2 recovery rate 278 constant, k) in a large group of smokers with or without COPD, using a non-invasive, relatively 279 simple, short-duration assessment by NIRS. Fifty-six out of 60 participants (93%) tolerated the NIRS 280 assessment and returned interpretable results. Overall these data showed: there was no mean bias 281 between test-retest repeats of gastrocnemius k measurement by NIRS in both COPD patients and 282 age-similar smokers without airflow obstruction; that individual test-retest reproducibility was 283 high (CV = 9.9%, ICC = 0.9); and that k averaged 25 % less in COPD compared to smokers with 284 normal spirometry. Despite known muscle morphologic adaptations including increased fat and 285 fibrotic infiltration, inflammation, loss of type I fibers and mitochondrial density (Maltais et al., 286 2014), our findings support that the NIRS assessment is a reliable method to detect COPD-related 287 loss of muscle oxidative capacity. 288
289
We also aimed to identify correlates of tests with reproducibility that lay outside 1 SD of the 290 distribution of all tests, as potential features for quality control. 13 of 56 participants (5 COPD, 8 291 CON) showed a high variability in k (k > 0.3 min -1 , which was the mean effect size of COPD). Poor 292 reproducibly was not associated with presence of COPD. Poor reproducibility was explained 293 principally by a small increase in O2 and only modest deoxygenation during contractions. This 294 suggests that insufficient contractile stimulus for mitochondrial activation and/or that the NIRS 295 signal contained little light reflected from active muscle (large adipose layer in n=6, and high skin 296 melanin content in n=6), may contribute to poor test quality. These findings indicate that a poor 297 quality tests are related to an insufficient increase in O2 during contractions, and not to the 298 presence of an O2 delivery limitation, as might be anticipated in COPD. 299 300
Muscle oxidative capacity in COPD 301
We found that k in the gastrocnemius skeletal muscle was, on average, 25 % less (range ~12-30%) 302
in COPD than smokers of a similar age but without pulmonary obstruction. This average is 303 consistent with the ~10-50% lower muscle oxidative enzyme activity (e.g. citrate synthase) or 304 oxidative capacity observed in quadriceps biopsy samples from COPD patients compared withcontrols (Meyer et al., 2013) , suggesting that the NIRS test provides a relevant non-invasive 306 alternative to invasive biopsy assessments . It is of note that k in our control 307 group was 25% lower than non-smoking control participants in other studies using the same NIRS 308 methods (non-smoker gastrocnemius k = ~2 min -1 equivalent to an oxidative capacity of ~250 309 pmol.s -1 .mg dry weight -1 ; Ryan et al., 2014). However, those studies almost exclusively included 310 young participants aged 24-27 years, while our smokers ranged 49-77 years. Whether the 311 apparently low muscle oxidative capacity in our study relates to the effects of long-term smoking, or 312 alternatively to age or physical inactivity remains to be determined. 313 314 While our study was not sufficiently powered to detect differences across disease severity, one 315 outlier of the three GOLD 4 patients (k = 2.12 min -1 ) likely skewed a general trend for a progressive 316 decline in oxidative capacity across GOLD severity classifications 2-4. Even so, the distribution of k 317 values among the 28 COPD patients suggests that low k may occur at any GOLD stage, and therefore 318 muscle dysfunction may not be solely associated with the disease severity in COPD (Maltais et al., 319 2014; Wagner, 2006 ). The precise etiologies resulting in loss of muscle oxidative capacity in COPD 320 awaits further research. Nevertheless, the 93% tolerability and good test-retest agreement of the 321 NIRS test in COPD prove the feasibility and reliability of this approach for discriminating patients 322 with poor muscle function i.e. gastrocnemius k value lower than the 2 min -1 reference for a healthy 323 adult. Because the NIRS test is non-invasive, it may provide the opportunity for muscle assessment 324 in large-cohort studies, which are needed to better identify the complex multifactorial etiology of 325 muscle oxidative dysfunction in COPD. 326 327
Variables influencing reproducibility of the NIRS muscle oxidative capacity test 328
The NIRS assessment of muscle oxidative capacity relies on the observed linear proportionality 329 between the recovery rate constant (k) of cellular O2 and cellular oxidative capacity i.e. the O2max 330 of the muscle cells investigated (Wüst et al., 2013) . The primary predictor in our study of poor k 331 reproducibility was a high value for k (r 2 = 0.17; P 0.001). This is likely a simple reflection of the 332 limited ability to accurately model the recovery rate constant with a limited number of O2 333 measurements when O2 kinetics are rapid. Nevertheless, this does not limit the ability of the test 334 to detect abnormally low muscle oxidative capacity, which is the primary aim for studies of COPD 335 patients or other conditions of chronic inactivity or disease. 336
The under normoxic conditions. However, during hypoxic gas breathing, PCr recovery kinetics were 368 slowed. It should be pointed out that the duration of exercise was 6 min, and therefore m O2 andmuscle deoxygenation were likely far greater than those observed in our study where exercise was 370 limited to ~15 s. Nevertheless, were TSI to be driven below some limiting value, O2 recovery k 371 may become limited by O2 delivery in vivo, which would result in an erroneously low k. While the 372 brief exercise in the NIRS test does not strain central cardiac or pulmonary limits for O2 delivery, 373 age-or disease-related chronic adaptations, such as muscle capillary rarefaction, inflammation, 374 anemia or reduced muscle myoglobin (Maltais et al., 2014 ), have the potential to limit muscle 375 mitochondrial O2 concentration in COPD and therefore invalidate the NIRS assessment. However, 376
we found that the lowest value of TSI measured during the NIRS assessment (TSILOW; typically 377 reached during the 1 st or 2 nd post-exercise arterial occlusion) was not related to poor test-retest 378 reliability of k. This suggests that outlying low k values are not consequent to O2 delivery limitation, 379 at least down to TSILOW values of ~30% of the physiologic range. 380 381
Quality control of the muscle NIRS oxidative capacity assessment 382
In part, the beauty of the NIRS test of muscle oxidative capacity is that it relies on O2 kinetics, and 383 therefore does not require calibrated measurements. For this reason, one aim of this study was to 384 identify variables that could be used as markers of quality control. We proposed to identify features 385 within any tests that showed poor reproducibility. The strongest correlate of variability in repeated 386 k measurements (k) was the value of k itself, which does not provide a basis for quality control. To 387 our surprise, however, we found no correlation between k and proposed quality assessments (e.g. 388 increase in m O2 increase during contractions or low TSI during occlusions). This may reflect the 389 overall strong test-retest reproducibility in COPD patients and controls. We therefore identified 13 390 participants in whom variability exceeded 1 SD (k > 0.3 min -1 ). Of these 13, there was a high 391 prevalence of large ATT, high skin melanin content, low increase in m O2 and a small exercise-392 induced deoxygenation. While these features alone do not form the basis of quality control, they 393 highlight that patient physical characteristics limiting reflected light from active muscle tissue are 394 likely partly responsible for reducing reproducibility of k measurements. Alternative NIRS systems, 395 such as high-power time-resolved (TRS) NIRS, allow deeper penetration into muscle during rest and 396 exercise (Okushima et al., 2015) , and therefore may increase the reliability of m O2 recovery kinetic 397 assessment in these patients. 398 399 Based on our findings and experience, a few considerations emerge to inform quality control of the 400 measurement twice in the same visit. We propose that poorly-reproducible tests, where k > 0.3 402 min -1 , be repeated to reduce the influence of outlying results, and repeated measurements averaged. 403
Careful attention should be made to the NIRS probe placement, to ensure that a muscle region is 404 chosen that both minimizes the skinfold under the probe and maximizes the sampling of active 405 muscle during contractions and recovery. Doppler ultrasound, skinfold calipers, muscle palpation 406 during contraction and/or surface EMG may help to identify optimal NIRS probe placement. 407
408
Exercise stimuli that result in a small increase O2 and small reduction in saturation were 409 associated with poor test reliability. Therefore, our data suggest that the risk to NIRS test validity of 410 under-stimulating the muscle during dynamic contractions is greater than the risk of O2 
Clinical implications 426
Low muscle oxidative capacity is associated with exercise intolerance in COPD and therefore may 427 contribute to reduce physical activity and quality of life in these patients (Maltais et al., 2014; Meyer 428 et al., 2013) . We studied the gastrocnenius muscle as a primary locomotor muscle for walking, and 429 which is also extensively activated during standing and in sway. Rehabilitation (cycling and 430 walking) is known to ameliorate oxidative capacity deficits in quadriceps (Maltais et al., 1996) and 431 is associated with a reduction of dyspnea and leg fatigue symptoms during exercise in COPD. 432
Therefore, reliable measurements of skeletal muscle structure and function, independent of diseaserelated impairments in pulmonary function or muscle blood flow, are of crucial importance to 434 monitor the peripheral consequences of COPD. This reliable, non-invasive, short-duration, relatively 435 inexpensive and well-tolerated assessment of oxidative capacity in COPD muscle may also enable a 436 better targeting to therapeutic strategies to improve physical activity, exercise tolerance and quality 437 of life in these patients. 438 assessed reliability in 15 participants whereas our study investigated 56. This difference also 448 contributes to the greater ICC found in our study. Nevertheless, our data show that the approach is 449 reliable in COPD and older controls where muscle quality is reduced compared with young subjects. 450 451 Furthermore, Southern et al. (2013) found greater day to day test-retest variability of the NIRS 452 oxidative capacity test when using self-metered exercise (specifically, exercise against elastic 453 resistance bands) compared with monitored exercise using a custom-built plantar flexion 454 ergometer. We were specifically interested in assessing a pragmatic approach to the NIRS oxidative 455 capacity test using self-metered exercise in order to assess the applicability of the assessment in the 456 clinical setting without the requirement for additional specialized equipment. We used a manually-457 applied resistance to plantar flexion administered by the same researcher in all participants. The 458 intensity of the 10-15 contractions was assessed indirectly by feel and also monitored in the TSI 459 trace in real time. This meant that the operator could instruct the participant to alter the intensity 460 or duration of contractions during the test itself to achieve an optimal deoxygenation signal (and, 461 by implication, O2 response). We believe that this approach might have advantages over delivery 462 of a standardized metered exercise dose in patients with chronic disease where there is wide 463 variability in O2 delivery and O2 utilization responsiveness. Our high ICC values for k support the 464 suggestion, and that our pragmatic approach provides a reliable assessment of muscle oxidative 465 capacity suitable for clinical research or routine assessment in COPD patients. 466 467
Limitations 468
There are few limitations to report for this study. The CON group were slightly, but significantly 469 younger than the COPD patients (Table 1) . It is possible that the younger age in CON may contribute 470 to the mean effect size of k in COPD (-0.3 min -1 ). Nevertheless, the average difference in age was 471 small (5 years on an average age of 65 years), and is not the only variable that affects muscle 472 oxidative capacity. For example, physical activity, occupation, drug therapies and comorbidities are 473 expected to play a significant role in the etiology of loss of muscle oxidative capacity in COPD 474 (Maltais et al., 2014; Wagner, 2006) . 475
476
Two COPD patients used nasal cannula O2 delivery during the NIRS assessment. However, these 477 participants data lay well within the range of the group as a whole (k was -0.05 and -0.13 min -1 ). 478
We could identify no reason additional to treat these data differently from the group. In addition, 479 while baseline arterial O2 saturation was measured by pulse oximetry, we found no influence of 480 SpO2 on the reproducibility of k. The brief single leg plantar-flexion contractions were insufficient to 481 alter SpO2 and we found no differences in muscle HbO2 among the 13 participants with poor 482 reproducibility of k and the rest of the group. We therefore believe that arterial oxygenation did not 483 influence our results. However, this should be monitored in future studies to ensure that the 484 assumption of constant SpO2 is met. 
CONCLUSION 494
We found that a non-invasive NIRS-based assessment of oxidative capacity of gastrocnemius muscle 495 was well tolerated and reliable in middle-aged to elderly smokers with or without COPD. Our datawere consistent with direct assessment of muscle citrate synthase activity or oxidative capacity 497 from biopsy studies (Meyer et al., 2013) in that gastrocnemius k (a direct correlate of muscle 498 oxidative capacity) was 25% lower in COPD than in smoker controls without pulmonary obstruction. 499
We found high test-retest reliability of the NIRS oxidative capacity test in both COPD (CV = 9.9%; 500 ICC = 0.88) and CON groups (CV = 9.9%; ICC = 0.93). Our attempts to identify objective markers of 501 NIRS test quality were less successful: nevertheless, performance of repeated assessments in the 502 same visit can identify outlying results, and these were associated with small O2 and 503 deoxygenation responses during dynamic contractions, and participants with a large skinfold or 504 high skin melanin. Together these data suggest that poor-quality assessments occur when the 505 exercise stimulus is insufficient for mitochondrial activation and/or the NIRS signal contains little 506 light reflected from active muscle. Low post-contraction TSI was unrelated to NIRS test reliability, 507
suggesting that O2 supply is sufficient for NIRS test validity at least down to TSI of ~30% of the 508 individuals physiologic range. Therefore it is recommended to err towards a more intense exercise 509 rather than the maintenance of a high muscle oxygenation to optimize NIRS assessment of muscle 510 oxidative capacity. Our findings support the reliability of non-invasive muscle oxidative capacity 511 assessment by NIRS in COPD, which may be helpful to track the efficacy of interventions in COPD 512 such as pulmonary rehabilitation that are designed to redress skeletal muscle dysfunction. 
